Semaglutide
A GLP-1 receptor agonist used for type 2 diabetes and, since FDA approval in 2021, for weight management. It helps the pancreas release insulin when blood sugar is high, slows gastric emptying and reduces appetite. This is the one item on this page that is an approved medication for its stated use. It is covered in more detail on our weight management page.

